Table 4.
Test Utility in Stillbirths with a Possible or Probable Infection Cause of Death | ||||
---|---|---|---|---|
Test | Total Tested N (% of total infection cases) | Positive Result N (% of cases tested) | Pertinent Positive Result* N (% of cases tested) | Normal Placental Pathology and Autopsy with Positive Screening Test N (% of cases tested) |
Placental Pathology | 66 (100) | 63 (96) | 59 (89) | NA |
Fetal Autopsy | 66 (100) | 36 (55) | 36 (55) | NA |
Parvovirus Serology | 55 (83) | 5 (9) | 2 (4) | 3 (6) |
Syphilis Testing | 65 (99) | 1 (2) | 1 (2) | 0 |
Cytomegalovirus Serology | 11 (17) | 2 (18) | 2 (18) | 0 |
Herpes Simplex Virus Serology | 16 (24) | 2 (13) | 1 (6) | 0 |
Fetal Cultures | 47 (71) | 35 (75) | 25 (53) | 0 |
Placental Cultures | 5 (8) | 5 (100) | 1 (20) | 0 |
A pertinent positive result is a test result which confirms a clinically suspected cause of death or one which identifies a potential cause of death. Reference 10 describes the methodology behind our assessment of test utility in stillbirth evaluation.